These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37166764)

  • 1. Hepatitis A notifications in the EU/EEA, 2010-2019: what can we learn from case reporting to the European Surveillance System?
    Severi E; Tavoschi L; Carrillo-Santisteve P; Westrell T; Marrone G; Giesecke J; Lopalco P
    Euro Surveill; 2023 May; 28(19):. PubMed ID: 37166764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing hepatitis A epidemiology in the European Union: new challenges and opportunities.
    Gossner CM; Severi E; Danielsson N; Hutin Y; Coulombier D
    Euro Surveill; 2015 Apr; 20(16):. PubMed ID: 25953274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences between males and females in infectious diseases notifications in the EU/EEA, 2012 to 2021.
    Beauté J; Innocenti F
    Euro Surveill; 2024 Aug; 29(33):. PubMed ID: 39149823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Travel-associated hepatitis A in Europe, 2009 to 2015.
    Beauté J; Westrell T; Schmid D; Müller L; Epstein J; Kontio M; Couturier E; Faber M; Mellou K; Borg ML; Friesema I; Vold L; Severi E
    Euro Surveill; 2018 May; 23(22):. PubMed ID: 29871720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence and susceptibility to hepatitis A in the European Union and European Economic Area: a systematic review.
    Carrillo-Santisteve P; Tavoschi L; Severi E; Bonfigli S; Edelstein M; Byström E; Lopalco P;
    Lancet Infect Dis; 2017 Oct; 17(10):e306-e319. PubMed ID: 28645862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Legionnaires' disease in the EU/EEA*: increasing trend from 2017 to 2019.
    Samuelsson J; Payne Hallström L; Marrone G; Gomes Dias J
    Euro Surveill; 2023 Mar; 28(11):. PubMed ID: 36927719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Migration-related tuberculosis: epidemiology and characteristics of tuberculosis cases originating outside the European Union and European Economic Area, 2007 to 2013.
    Ködmön C; Zucs P; van der Werf MJ
    Euro Surveill; 2016; 21(12):. PubMed ID: 27039665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of migration within the European Union/European Economic Area on the distribution of tuberculosis, 2007 to 2013.
    Hollo V; Kotila SM; Ködmön C; Zucs P; van der Werf MJ
    Euro Surveill; 2016; 21(12):. PubMed ID: 27035746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three simultaneous, food-borne, multi-country outbreaks of hepatitis A virus infection reported in EPIS-FWD in 2013: what does it mean for the European Union?
    Gossner CM; Severi E
    Euro Surveill; 2014 Oct; 19(43):. PubMed ID: 25375903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis surveillance in adolescents: what to learn from European Union/European Economic Area data?
    Kohlenberg A; Ködmön C; van den Boom M; van der Werf MJ
    Int J Tuberc Lung Dis; 2020 Mar; 24(3):347-352. PubMed ID: 32228766
    [No Abstract]   [Full Text] [Related]  

  • 11. Epidemiology of reported cases of leptospirosis in the EU/EEA, 2010 to 2021.
    Beauté J; Innocenti F; Aristodimou A; Špačková M; Eves C; Kerbo N; Rimhanen-Finne R; Picardeau M; Faber M; Dougas G; Halldórsdóttir AM; Jackson S; Leitēna V; Vergison A; Borg ML; Pijnacker R; Sadkowska-Todys M; Martins JV; Rusu LC; Grilc E; Estévez-Reboredo RM; Niskanen T; Westrell T
    Euro Surveill; 2024 Feb; 29(7):. PubMed ID: 38362624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving preparedness to respond to cross-border hepatitis A outbreaks in the European Union/European Economic Area: towards comparable sequencing of hepatitis A virus.
    Enkirch T; Severi E; Vennema H; Thornton L; Dean J; Borg ML; Ciccaglione AR; Bruni R; Christova I; Ngui SL; Balogun K; Němeček V; Kontio M; Takács M; Hettmann A; Korotinska R; Löve A; Avellón A; Muñoz-Chimeno M; de Sousa R; Janta D; Epštein J; Klamer S; Suin V; Aberle SW; Holzmann H; Mellou K; Ederth JL; Sundqvist L; Roque-Afonso AM; Filipović SK; Poljak M; Vold L; Stene-Johansen K; Midgley S; Fischer TK; Faber M; Wenzel JJ; Takkinen J; Leitmeyer K
    Euro Surveill; 2019 Jul; 24(28):. PubMed ID: 31311618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced surveillance of hepatitis C in the EU, 2006 - 2012.
    Duffell EF; van de Laar MJ; Amato-Gauci AJ
    J Viral Hepat; 2015 Jul; 22(7):590-5. PubMed ID: 25420699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced surveillance of hepatitis B in the EU, 2006-2012.
    Duffell EF; van de Laar MJ; Amato-Gauci AJ
    J Viral Hepat; 2015 Jul; 22(7):581-9. PubMed ID: 25417854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis A occurrence and outbreaks in Europe over the past two decades: A systematic review.
    Andani A; Bunge E; Kassianos G; Eeuwijk J; Mellou K; Van Damme P; Mukherjee P; Steffen R
    J Viral Hepat; 2023 Jun; 30(6):497-511. PubMed ID: 36825922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated digital reporting of clinical laboratory information to national public health surveillance systems, results of a EU/EEA survey, 2018.
    Leitmeyer KC; Espinosa L; Broberg EK; Struelens MJ; ;
    Euro Surveill; 2020 Oct; 25(39):. PubMed ID: 33006301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardising surveillance of hepatitis E virus infection in the EU/EEA: A review of national practices and suggestions for the way forward.
    Adlhoch C; Manďáková Z; Ethelberg S; Epštein J; Rimhanen-Finne R; Figoni J; Baylis SA; Faber M; Mellou K; Murphy N; O'Gorman J; Tosti ME; Ciccaglione AR; Hofhuis A; Zaaijer H; Lange H; de Sousa R; Avellón A; Sundqvist L; Said B; Ijaz S
    J Clin Virol; 2019 Nov; 120():63-67. PubMed ID: 31590112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severity of the clinical presentation of hepatitis A in five European countries from 1995 to 2014.
    Severi E; Georgalis L; Pijnacker R; Veneti L; Turiac IA; Chiesa F; Rizzo C; Martinelli D; Vold L; Herrador BG; Martinez CV; Sanchez EVM; Semenza JC; Lopalco P; Dahlström LA; Giesecke J
    Int J Infect Dis; 2022 May; 118():34-43. PubMed ID: 35134558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial resistance in
    Hernando Rovirola C; Spiteri G; Sabidó M; Montoliu A; Gonzalez V; Casabona J; Cole MJ; Noori T; Unemo M
    Sex Transm Infect; 2020 May; 96(3):204-210. PubMed ID: 32019895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant increase in azithromycin "resistance" and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019.
    Day MJ; Jacobsson S; Spiteri G; Kulishev C; Sajedi N; Woodford N; Blumel B; van der Werf MJ; Amato-Gauci AJ; Unemo M; Cole MJ;
    BMC Infect Dis; 2022 Jun; 22(1):524. PubMed ID: 35672671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.